Gall Jonathan M, Wang Zhiyong, Bonegio Ramon G, Havasi Andrea, Liesa Marc, Vemula Pradheep, Borkan Steven C
Renal Section and.
The Obesity Center, Boston Medical Center, Boston, Massachusetts.
J Am Soc Nephrol. 2015 May;26(5):1092-102. doi: 10.1681/ASN.2014010126. Epub 2014 Sep 8.
Proximal tubule (PT) cells are critical targets of acute ischemic injury. Elimination of the mitochondrial fusion protein mitofusin 2 (Mfn2) sensitizes PT cells to apoptosis in vitro. However, the role of PT Mfn2 in ischemic AKI in vivo is unknown. To test its role, we evaluated the effects of conditional KO of PT Mfn2 (cKO-PT-Mfn2) on animal survival after transient bilateral renal ischemia associated with severe AKI. Forty-eight hours after ischemia, 28% of control mice survived compared with 86% of cKO-PT-Mfn2 animals (P<0.001 versus control). Although no significant differences in histologic injury score, apoptosis, or necrosis were detected between genotypes, cKO-PT-Mfn2 kidneys exhibited a 3.5-fold increase in cell proliferation restricted to the intrarenal region with Mfn2 deletion. To identify the signals responsible for increased proliferation, primary PT cells with Mfn2 deficiency were subjected to stress by ATP depletion in vitro. Compared with normal Mfn2 expression, Mfn2 deficiency significantly increased PT cell proliferation and persistently activated extracellular signal-regulated kinase 1/2 (ERK1/2) during recovery from stress. Furthermore, stress and Mfn2 deficiency decreased the interaction between Mfn2 and Ras detected by immunoprecipitation, and purified Mfn2 dose-dependently decreased Ras activity in a cell-free assay. Ischemia in vivo also reduced the Mfn2-RAS interaction and increased both RAS and p-ERK1/2 activity in the renal cortical homogenates of cKO-PT-Mfn2 mice. Our results suggest that, in contrast to its proapoptotic effects in vitro, selective PT Mfn2 deficiency accelerates recovery of renal function and enhances animal survival after ischemic AKI in vivo, partly by increasing Ras-ERK-mediated cell proliferation.
近端小管(PT)细胞是急性缺血性损伤的关键靶点。线粒体融合蛋白线粒体融合素2(Mfn2)的缺失会使PT细胞在体外对凋亡敏感。然而,PT Mfn2在体内缺血性急性肾损伤(AKI)中的作用尚不清楚。为了测试其作用,我们评估了PT Mfn2条件性敲除(cKO-PT-Mfn2)对与严重AKI相关的短暂双侧肾缺血后动物存活的影响。缺血48小时后,对照小鼠的存活率为28%,而cKO-PT-Mfn2动物的存活率为86%(与对照相比,P<0.001)。尽管在基因型之间未检测到组织学损伤评分、凋亡或坏死的显著差异,但cKO-PT-Mfn2肾脏中局限于肾内区域且Mfn2缺失的细胞增殖增加了3.5倍。为了确定导致增殖增加的信号,体外通过ATP耗竭对缺乏Mfn2的原代PT细胞施加应激。与正常Mfn2表达相比,Mfn2缺乏显著增加了PT细胞增殖,并在应激恢复过程中持续激活细胞外信号调节激酶1/2(ERK1/2)。此外,应激和Mfn2缺乏减少了免疫沉淀检测到的Mfn2与Ras之间的相互作用,并且在无细胞试验中纯化的Mfn2剂量依赖性地降低了Ras活性。体内缺血也减少了cKO-PT-Mfn2小鼠肾皮质匀浆中的Mfn2-RAS相互作用,并增加了RAS和p-ERK1/2活性。我们的结果表明,与其在体外的促凋亡作用相反,选择性PT Mfn2缺乏可加速肾功能恢复并提高体内缺血性AKI后动物的存活率,部分原因是增加了Ras-ERK介导的细胞增殖。